Ligand Pharmaceuticals Inc (LGND, LGNDZ, LGNXZ, LGNYZ, LGNZZ)

CIK 886163 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Ligand Pharmaceuticals Inc.

Recent SEC filings

FiledFormAccession number
Sep 10, 20261440001950047-26-009263
Sep 8, 202640002001011-26-000137
Sep 3, 20261440001950047-26-009091
Sep 2, 20268-K/A0000886163-26-000048
Aug 14, 202640002001011-26-000114
Aug 14, 202640002001011-26-000115
Aug 13, 2026SCHEDULE 13G0000914208-26-000299
Aug 12, 20261440001950047-26-008026
Aug 12, 20261440001950047-26-008011
Aug 7, 202610-Q0000886163-26-000044
Aug 6, 20268-K0000886163-26-000041
Aug 4, 202640002001011-26-000111
Jul 22, 2026S-80001193125-26-312502
Jul 14, 20268-K0001193125-26-302660
Jul 6, 202640002001011-26-000106
Jul 6, 202640002001011-26-000107
Jul 6, 202640002001011-26-000108
Jul 1, 20261440001950047-26-006760
Jun 25, 20268-K0001193125-26-282990
Jun 22, 20268-K0001193125-26-276694
Jun 18, 202640001104659-26-075456
Jun 16, 20261440001950047-26-006193
Jun 15, 202640002001011-26-000104
Jun 12, 20261440001950047-26-005992
Jun 12, 202640002001011-26-000102